Abstract
Yadanzi, Fructus Bruceae, is the dry mature fruit of Brucea javanica (L.) Merr (Simaroubaceae). It is used in traditional Chinese medicine for a long time as an antimalarial and antidysenterie agent. By external application, it was also used for treatment of warts and corns. The fruit of B. javanica is listed officially in the Chinese Pharmacopoeia.
Access this chapter
Tax calculation will be finalised at checkout
Purchases are for personal use only
Preview
Unable to display preview. Download preview PDF.
References
Polonsky J, Baskevitch Z, Gandemer A, Das BC (1967) Constituants amers de Brucea amarissima, structures des bruceines A, B et C. Experientia 23:424–426
Yoshimura S, Sakaki T, Ishibashi M, Tsuyuki T, Takahashi T, Matsushita K, Honda T (1984) Structures of yadanziolides A, B and C, new bitter principles from Brucea javanica Chem Pharm Bull 32:4698–4701
Yoshimura T, Sakaki T, Ishibashi N, Tsuyuki T, Takahashi T, Honda T (1985) Constituents of seeds of Brucea javanica Structures of new bitter principles, yadanziolides A, B, C, Yadanziosides F, I, J and L. Bull Chem Soc Jpn 58:2673–2679
Sakaki T, Yoshimura S, Ishibashi M, Tsuyuki T, Takahashi T, Honda T, Nakanishi T (1984) New quassinoid glycosides, yadanziosides A-H, from Brucea javanica Chem Pharm Bull 32:4702–4705
Sakaki T, Yoshimura S, Ishibashi M, Tsuyuki T, Takahashi T, Honda T, Nakanishi T (1985) Structures of new quassinoid glycosides, yadanziosides A, B, C, D, E, G, H and new quassi-noids, dehydrobrusatol and dehydrobruceantinol from Brucea javanica (L.) Merr. Bull Chem Soc Jpn 58:2680–2686
Polonsky J (1973) Quassinoid bitter principles. In: Herz W, Grisebach H, Kirby GW (eds) Progress in the Chemistry of Organic Natural Products, Vol 30. Springer, Berlin Heidelberg New York, pp 101–150
Polonsky J (1985) Quassinoid bitter principles. IL In: Herz W, Grisebach H, Kirby GW, Tamm C (eds) Progress in the Chemistry of Organic Natural Products, Vol 47. Springer, Berlin Heidelberg New York, pp 221–264
Heathcock GH, Mahaim C, Schlecht MF, Utawanit T (1984) A synthetic approach to the quassinoids. J Org Chem 49:3264–3274
Kerwin SM, Paul AG, Heathcock CH (1987) Quassinoid synthesis. II. Preparation of a tetracyclic intermediate having the bruceantin tetrahydrofuran ring. J Org Chem 52:1686–1695
Shishido K, Saitoh T, Fukumoto K, Kametani T (1983) Stereoselective synthesis of the penta-cyclic system as a model for bruceantin. J Chem Soc Chem Commun 852–853
Okano M, Lee KH (1981) Antitumor agents. XLIII. Conversion of bruceoside A into bruceantin. J Org Chem 46:1138–1141
Lee KH, Yamagishi T (1987) Antineoplastic terpenoids from Chinese medicinal plants. Abstr Chin Med 1:606–625
Kupchan SM, Britton RW, Ziegler MF, Sigel CW (1973) Bruceantin, a new potent antileukemic simaroubalide from Brucea antidysenterica J Org Chem 38:178–179
Kupchan SM, Britton RW, Lacadie JA, Ziegler MF, Sigel CW (1975) The isolation and structural elucidation of bruceantin and bruceantinol, new potent antileukemic quassinoids from Brucea antidysenterica J Org Chem 40:648–654
Darwish FA, Evans JF, Phillipson JD (1979) Cytotoxic bruceolides from Brucea javanica J Pharm Pharmacol [Suppl] 31:10
Lee KH, Imakura Y, Huang HC (1977) Bruceoside A, a novel antileukemic quassinoid glycoside from Brucea javanica J Chem Soc Chem Commun 69–70, 22
Cassady JM, Suffness M (1980) Terpenoid antitumor agents. (Anticancer agents based on natural product models.) Med Chem (Academic) 16:201–269
Johnson RK, Chitnis MP, Embrey WM, Gregory EB (1978) In vivo characteristics of resistance and cross resistance of an adriamycin-resistant subline of P388 leukemia. Cancer Treat Rep 62:1535–1547
Hall IH, Lee KH, Okano M, Sims D, Ibuka T, Liou YF, Imakura Y (1981) Antitumor agents. XLII. Comparison of antileukemic activity of helenalin, brusatol and bruceantin and their esters on different strains of P388 lymphocytic leukemic cells. J Pharm Sci 70:1147–1150
Liao LL, Kupchan SM, Horwith SB (1976) Mode of action of the antitumor compound bruceantin, an inhibitor of protein synthesis. Mol Pharmacol 12:167–176
Fresno M, Gonzales A, Vazquez D, Jimenez A (1978) Bruceantin, a novel inhibitor of peptide bond formation. Biochim Biophys Acta 518:104–112
Suling WJ, Woolley CW, Shannon WM (1979) Disposition and metabolism of bruceantin in the mouse. Cancer Chemother Pharmacol 3:171–176
Fong KLL, Ho DHW, Carter CJK, Brown NS, Benjamin RS, Freireich EJ, Bodey GP (1980) Radioimmunoassay for the detection and quantitation of bruceantin. Anal Biochem 105:281–286
Castles TR, Bhandari JC, Lee CC, Guarino AM (1976) Preclinical toxicologic evaluation of bruceantin (NSC-165,563) in mice, dogs and monkeys. US National Technical Information Service, Springfield, p 348 (PB-257175)
Castles TR, Bhandari JE, Lee CC, Guarino AM, Cooney DA (1977) Preclinical toxicologic evaluation of bruceantin (NSC-165,563) in dogs. US National Technical Information Service, Springfield, p 56 (PB-269584)
Bedikian AY, Valdivieso M, Bodey GP, Murphy WK, Freireich E (1979) Initial clinical studies with bruceantin. Cancer Treat Rep 63:1843–1847
Liesmann J, Belt RJ, Haas CD, Hoogstraten B (1981) Phase I study on bruceantin administration on a weekly schedule. Cancer Treat Rep 65:883–885
Lee KH, Okano M, Hall IH, Brent DA, Soltmann B (1982) Antitumor agents. XLV. Bisbrusa-tolyl and brusatolyl esters and related compounds as novel potent antileukemic agents. J Pharm Sci 71:338–348
Kupchan SM, Lacadie JA, Howie GA, Sickles BR (1976) Structural requirements for biological activity among antileukemic glaucarubalone ester quassinoids. J Med Chem 19:1130–1133
Suntory Ltd (1985) Bruceolide derivatives. Jpn Kokai Tokkyo Koho JP 6032,793(8532793) (CA 102:221041 r)
Liou YF, Hall IH, Okano M, Lee KH, Chaney SG (1982) Antitumor agents. XLVIII. Structure-activity relationship of quassinoids as in vitro protein synthesis inhibitors of P388 lymphocytic leukemia tumor cell metabolism. J Pharm Sci 71:430–435
Hall IH, Liou YF, Lee KH, Chaney SG, Willingham W Jr (1983) Antitumor agents. LIX. Effects of quassinoids on protein synthesis of a number of murine tumors and normal cells. J Pharm Sci 72:626–630
Hall IH, Liou YF, Okano M, Lee KH (1982) Antitumor agents. XLVI. In vitro effects of esters of brusatol, bisbrusatol and related compounds on nucleic acid and protein synthesis of P388 lymphocytic leukemia cells. J Pharm Sci 71:345–348
Eigebaly SA, Hall IH, Lee KH, Sumida Y, Imakura Y, Wu RY (1979) Antitumor agents. XXXV. Effect of brusatol, bruceoside A and bruceantin on P388 lymphocytic leukemia cell respiration. J Pharm Sci 68:877–890
Hall IH, Lee KH, Eigebaly SA, Imakura Y, Sumida Y, Wu RY (1979) Antitumor agents. XXXIV. Mechanism of action of bruceoside A and brusatol on nucleic acid metabolism of P388 lymphocytic leukemic cells. J Pharm Sci 68:883–887
Guru PY, Warhurst DC, Harris A, Phillipson JD (1983) Antimalarial activity of bruceantin in vitro. Ann Trop Med Parasitol 77:433–435
Lee LK (1982) Bruceolides. US Patent 4,350,638
Gillin FD, Reiner DS (1982) In vitro activity of certain quassinoid antitumor agents against Entamoeba histolytica Arch Invest Med [Suppl 3] 13:43–49
Gillin FD, Reiner DS, Suffness M (1982) Bruceantin, a potent amebicide from a plant, Brucea antidysenterica Antimierob Agents Chemother 22:342–345
Hall IH, Lee KH, Imakura Y, Okano M, Johnson A (1983) Antiinflammatory agents. III. Structure-activity relationships of brusatol and related quassinoids. J Pharm Sci 72:1282–1284
Zhang ZL, Wang GZ (1985) Report on a case of anaphylactic shock and atrial fibrillation after external application of Fructus Bruceae. Jilin Med J 6:674
Zheng GQ, Mao LZ, Xia WZ, Zhang GP (1986) A report on three cases of anaphylaxis caused by external application of the fruit of Brucea javanica Bull Chin Mat Med 11:121
Polonsky J, Baskevitch Z, Das BC, Müller J (1968) Sur les constituants amers du Brucea amarissima structures des bruceines D et E. C R Acad Sci [C] 267:1346–1349
Polonsky J, Baskevitch Z, Müller J (1969) Constituants amers du Brucea amarissima structure de la bruceine F. C R Acad Sci [C] 268:1392
Duncan GR, Henderson GB (1968) Bruceines from Brucea sumatrana the structure of bruceine G. Experientia 24:768–769
Sim KY, Sims J, Geissman TA (1968) Constituents of Brucea sumatrana Roxb. I. Brusatol. J Org Chem 33:429–431
Stöcklin W, Geissman TA (1968) A new bitter principle from Brucea sumatrana Roxb. Tetrahedron Lett 6007–6010
Lee KH, Imakura Y, Sumida Y, Wu RY, Hall JH, Huang HC (1979) Antitumor agents 33. Isolation and structural elucidation of bruceoside-A and -B, novel antileukemic quassinoid glycosides and bruceine-D and -E from Brucea javanica J Org Chem 44:2180–2185
Polonsky J, Verenne J, Prange T, Pascard C (1980) Antileukemic quassinoids: structure (X-ray analysis) of bruceine C and revised structure of bruceantinol. Tetrahedron Lett 1853–1856
Phillipson JD, Darwish FA (1979) TLX-5-lymphoma cells in rapid screening for cytotoxicity in Brucea extract. Planta Med 35:308–315
Phillipson JD, Darwish FA (1981) Bruceolides from Fijian Brucea javanica Planta Med 41:209–220
Chiang HC (1975) A new bitter principle from Brucea sumatrana Proc Natl Sci Counc (Taiwan) [A] 8:139–143 (CA 86,34173 z)
Sato Y, Hasegawa M, Suto N (1980) Identity of brusatol and yantansin, an antidysenteric agent. Agric Biol Chem 44:951–952
Zhang JS, Xu RS, Li YH, Chen ZL (1984) Chemical constituents of Brucea javanica III. Bruceene — isolation and structure of a new quassinoid from Brucea javanica Acta Chim Sin 42:684–687
Li X, Tso SH (1980) Studies on the anticancer principles in the seed of yadanzi (Brucea javanica) III. Isolation and structural elucidation of bruceoside A, bruceoside B, Bruceine E and bruceine F. Chin Trad Herb Drugs 11:530–532
Xie JX, Ji Z (1981) Chemical constituents of the Chinese medicinal herb Brucea javanica I. Isolation and identification of daucosterol, bruceine D and bruceine E. Acta Pharm Sin 16:53 – 55
Lin LZ, Zhang JS, Chen ZL, Xu RS (1982) Studies on the chemical constituents of Brucea javanica (L.) Merr. I. Isolation and identification of bruceaketolic acid and other four quassinoids. Acta Chim Sin 40:73–78
Lin AQ, Liu SR, Ji Zheng, Xie JX (1982) Chemical constituents of the Chines drug “Yadanzi”. II. Isolation and identification of brusatol and bruceoside A. Beijing Shifan Daxue Xuebao, Ziran Kexueban 71–73
Zhang JS, Lin LZ, Chen ZL, Xu RS, Sun XY (1983) Studies on the chemical constituents of Brucea javanica II. Brucein-E-glucopyranoside. Acta Chim Sin 41:149–152
Fong KLL, Ho DHW, Benjamin RS, Brown NS, Bedikian A (1982) Clinical pharmacology of bruceantin by radioimmunoassay. Cancer Chemother Pharmacol 9:169–172
Li XA, Liu YN, Wang SX, Zhu YR (1986) The separation and identification of bruceine H in Brucea javanica J Shenyang Coll Pharm 3:192–193
Sakaki T, Yoshimura S, Tsuyuki T, Takahashi T, Honda T, Nakanishi T (1986) Structures of yadanziosides K, M, N and O, new quassinoid glycosides from Brucea javanica (L.) Merr. Bull Chem Soc Jpn 59:3541–3546
Sakaki T, Yoshimura S, Tsuyuki T, Takahashi T, Honda T (1986) Yadanzioside P, a new antileukemic quassinoid glycoside from Brucea javanica (L.) Merr with the 3–0-(β-D-glucopyra-nosyl)-bruceantin structure. Chem Pharm Bull 34:4447–4450
Author information
Authors and Affiliations
Rights and permissions
Copyright information
© 1992 Springer-Verlag Berlin Heidelberg
About this chapter
Cite this chapter
Tang, W., Eisenbrand, G. (1992). Brucea javanica (L.) Merr. In: Chinese Drugs of Plant Origin. Springer, Berlin, Heidelberg. https://doi.org/10.1007/978-3-642-73739-8_29
Download citation
DOI: https://doi.org/10.1007/978-3-642-73739-8_29
Publisher Name: Springer, Berlin, Heidelberg
Print ISBN: 978-3-642-73741-1
Online ISBN: 978-3-642-73739-8
eBook Packages: Springer Book Archive